Für eine Medizin von Morgen – BioNTech-Geschäftsbericht 2021

Following the successful development of the first mRNA vaccine, BioNTech looks into the future in its 2021 annual report: titled “For a Medicine of Tomorrow”, the report shows how the research team is working on further medical breakthroughs that rely on the power of the immune system. The report uses microscopic images and 3D graphics of pathogens and immune cells to focus on this fascinating world of the human immune system.